You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Refractory Ascites

Showing 1 - 25 of 9,336
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Point-of-Care Echocardiography to Assess Impact of Dynamic

Recruiting
  • Cirrhosis, Liver
  • +4 more
  • Echocardiographic assessment
  • Chandigarh, Delhi, India
    PGIMER
Jan 17, 2023

QOL and Sarcopenia in Patients With Ascites

Not yet recruiting
  • Ascites Hepatic
  • Ascites, Malignant
  • Quality of Life surveys
  • Philadelphia, Pennsylvania
    University of Pennsylvania Perelman School of Medicine
Feb 10, 2023

Ascites Trial in Houston (Albumin)

Recruiting
  • Ascites
  • Houston, Texas
    Baylor St' Lukes Medical center
May 10, 2023

Ascites Hepatic Trial in Alexandria (Empagliflozin 10 MG, Diuretics)

Recruiting
  • Ascites Hepatic
  • Alexandria, Egypt
    Alexandria University
Jun 18, 2022

Liver Cirrhosis, Cirrhosis, Ascites Trial in Redwood City (Empagliflozin 10 MG)

Recruiting
  • Liver Cirrhosis
  • +4 more
  • Empagliflozin 10 MG
  • Redwood City, California
    Stanford University Digestive Health Clinic
Mar 21, 2022

Ascites, Paracentesis, Cirrhosis Trial in France (Alphapump, Ascites puncture)

Recruiting
  • Ascites
  • +2 more
  • Alphapump
  • Ascites puncture
  • Amiens, France
  • +8 more
Jun 9, 2022

Refractory Ascites in Children With Cirrhosis Trial in New Delhi (Midodrine, Standard medical treatment)

Recruiting
  • Refractory Ascites in Children With Cirrhosis
  • New Delhi, India
    ILBS
Nov 11, 2021

Hepatic Encephalopathy, Cirrhosis, Liver Trial in Chicago (HepQuant)

Withdrawn
  • Hepatic Encephalopathy
  • Cirrhosis, Liver
  • HepQuant
  • Chicago, Illinois
    Northwestern University
Aug 5, 2022

Refractory Malignant Ascites Trial in Shanghai (Oncorine (H101))

Recruiting
  • Refractory Malignant Ascites
  • Oncorine (H101)
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 15, 2022

Refractory Malignant Ascites Trial in Shanghai (H101, Tislelizumab)

Recruiting
  • Refractory Malignant Ascites
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Apr 2, 2022

Liver Cirrhosis Trial in New Delhi (drug, biological, other)

Recruiting
  • Liver Cirrhosis
  • New Delhi, Delhi, India
    Institute of Liver & Biliary Sciences
Jun 12, 2021

Cirrhosis, Ascites Hepatic Trial in Richmond (Terlipressin acetate continuous infusion)

Completed
Has Results
  • Cirrhosis
  • Ascites Hepatic
  • Terlipressin acetate continuous infusion
  • Richmond, Virginia
    Hunter Holmes McGuire VA Medical Center
Jun 22, 2021

Point-of-Care Echocardiography to Assess Impact of Dynamic

Recruiting
  • Hepatorenal Syndrome
  • +4 more
  • Echocardiographic assessment
  • Chandigarh, Delhi, India
    PGIMER
Jun 21, 2022

Malignant Ascites Trial (Serplulimab, Molgramostim, Hypofractionated radiotherapy/Sterotactic body radiotherapy)

Not yet recruiting
  • Malignant Ascites
  • (no location specified)
Aug 11, 2022

Liver Cirrhosis, Ascites Trial in Winnipeg (device, procedure, biological)

Completed
  • Liver Cirrhosis
  • Ascites
  • Peritoneal Dialysis Catheter
  • +3 more
  • Winnipeg, Manitoba, Canada
    Health Sciences Centre
Apr 19, 2021

Refractory Ascites Trial (Albumin, Midodrine, Standard medical therapy (SMT))

Unknown status
  • Refractory Ascites
  • (no location specified)
Nov 3, 2020

Management of Malignant Ascites by Interventional Radiology

Withdrawn
  • Refractory Malignant Ascites
  • Paracentesis
  • +2 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Jan 11, 2022

Liver Diseases, Portal Hypertension, Cirrhosis, Liver Trial (Transjugular intrahepatic portosystemic shunt (TIPS), microwave

Not yet recruiting
  • Liver Diseases
  • +4 more
  • Transjugular intrahepatic portosystemic shunt (TIPS)
  • microwave ablation (MWA)
  • (no location specified)
Dec 17, 2020

Pleural Effusion, Malignant Trial (IFN-? and CIK cells, Tcm cells or CAR T cells)

Not yet recruiting
  • Pleural Effusion, Malignant
  • IFN-γ and CIK cells, Tcm cells or CAR T cells
  • (no location specified)
Mar 16, 2022

Ascites Hepatic Trial (PleurX catheter)

Completed
  • Ascites Hepatic
  • PleurX catheter
  • (no location specified)
Sep 24, 2020

Refractory Ascites, Children, Only Trial in Shibin Al Kawm (Midodrine 2.5 mg tab)

Unknown status
  • Refractory Ascites
  • Children, Only
  • Midodrine 2.5 mg tab
  • Shibīn Al Kawm, Menofiya, Egypt
    Pediatric Hepatology, Gastroenterology and Nutrition Department,
Aug 20, 2020

Liver Cirrhoses, Malignant Ascites Trial in Leipzig, Bern (Alfapump)

Recruiting
  • Liver Cirrhoses
  • Malignant Ascites
  • Alfapump
  • Leipzig, Germany
  • +1 more
Oct 23, 2020

Liver Cirrhosis, Refractory Ascites, Malignant Ascites Trial in Worldwide

Completed
  • Liver Cirrhosis
  • +2 more
    • Dresden, Germany
    • +12 more
    Oct 23, 2020

    Refractory Ovarian Cancer With Recurrent Symptomatic Malignant Ascites Trial in United States (BAX69 Single-Route Arm, BAX69

    Terminated
    Has Results
    • Refractory Ovarian Cancer With Recurrent Symptomatic Malignant Ascites
    • BAX69 Single-Route Arm
    • BAX69 Double-Route Arm
    • Miami, Florida
    • +5 more
    Dec 22, 2020

    Ascites Trial in New York (McGill Quality of Life Questionnaire and the European Organization for Research and Treatment of

    Completed
    • Ascites
    • McGill Quality of Life Questionnaire and the European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Feb 5, 2020